M1166 – Pathology report for tissue specimens produced from wide local excisions or re-excisions

Long description

Pathology report for tissue specimens produced from wide local excisions or re-excisions

Short description

Path rpt tis spec wle/reexc

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2023

Last change

January 1, 2023 – No change

Nearby M codes

• M1158 – Patient had history of immunocompromising conditions prior to or during the measurement period
• M1159 – Hospice services provided to patient any time during the measurement period
• M1160 – Patient had anaphylaxis due to the meningococcal vaccine any time on or before the patient's 13th birthday
• M1161 – Patient had anaphylaxis due to the tetanus, diphtheria or pertussis vaccine any time on or before the patient's 13th birthday
• M1162 – Patient had encephalitis due to the tetanus, diphtheria or pertussis vaccine any time on or before the patient's 13th birthday
• M1163 – Patient had anaphylaxis due to the hpv vaccine any time on or before the patient's 13th birthday
• M1164 – Patients with dementia any time during the patient's history through the end of the measurement period
• M1165 – Patients who use hospice services any time during the measurement period
• M1167 – In hospice or using hospice services during the measurement period
• M1168 – Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period
• M1169 – Documentation of medical reason(s) for not administering influenza vaccine (e.g., prior anaphylaxis due to the influenza vaccine)
• M1170 – Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period
• M1171 – Patient received at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period
• M1172 – Documentation of medical reason(s) for not administering td or tdap vaccine (e.g., prior anaphylaxis due to the td or tdap vaccine or history of encephalopathy within seven days after a previous dose of a td-containing vaccine)
• M1173 – Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period
• M1174 – Patient received at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period